Genentech Development and Commercialization Responsibilities Sample Clauses
The "Genentech Development and Commercialization Responsibilities" clause defines Genentech's obligations regarding the development and marketing of a product or technology under the agreement. It typically outlines Genentech's duties in conducting research, clinical trials, regulatory submissions, and subsequent commercialization activities such as manufacturing, distribution, and sales. This clause ensures that Genentech is clearly accountable for advancing the product through necessary stages and bringing it to market, thereby allocating responsibility and reducing ambiguity between the parties.
Genentech Development and Commercialization Responsibilities. The following provisions shall apply to the development and commercialization of Lead Products other than Collaboration Products:
(a) Clinical Development Responsibilities. Genentech or its sublicensees will be responsible for the clinical development of such Lead Products and will bear all associated costs. In addition, if required for IND filing, Genentech and/or its sublicensees will be responsible for conducting pharmacokinetics, toxicology or other IND-enabling studies with respect to such Lead Products. Genentech will use commercially reasonable efforts to develop and to obtain Regulatory Approval of such Lead Products in the Major Markets and such other markets as Genentech deems advisable in accordance with generally accepted practices in the pharmaceutical industry.
Genentech Development and Commercialization Responsibilities. Genentech shall be responsible for undertaking preclinical development, clinical development and commercialization of all Genentech Products at its cost. Genentech shall have sole decision-making authority on matters relating to Genentech Products. The following provisions shall apply to the development and commercialization of Genentech Products once they have been designated as a Genentech Product (which, in the case of Optioned Products, may be at a more advanced stage of development before they are actually designated as Genentech Products):